Announcements Trials

Browse Landscape

Phase

Status

Terminated 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Renal Cell 86 Kidney Neoplasms 25 Neoplasms 24 Breast Neoplasms 18 Gastrointestinal Stromal Tumors 17 Neoplasm Metastasis 15 Carcinoma, Non-Small-Cell Lung 15 Prostatic Neoplasms 8 Urinary Bladder Neoplasms 7 Brain Neoplasms 7 Pancreatic Neoplasms 6 Lung Neoplasms 6 Colorectal Neoplasms 6 Thyroid Neoplasms 5 Stomach Neoplasms 5 Solid Tumors 5 Small Cell Lung Carcinoma 5 Ovarian Neoplasms 5 Neuroendocrine Tumors 5 Melanoma 5 Glioblastoma 5 Carcinoma 5 Sarcoma 4 Liver Neoplasms 4 Esophageal Neoplasms 4 Clear-cell metastatic renal cell carcinoma 4 Carcinoma, Hepatocellular 4 Astrocytoma 4 Adenoma, Islet Cell 4 Thyroid Cancer, Papillary 3

Interventions

Nivolumab 13 Surveys and Questionnaires 6 Ipilimumab 6 linrodostat 5 Standard of Care 5 Paclitaxel 5 Bevacizumab 5 Sirolimus 4 Pemetrexed 4 Interviews as Topic 4 Gemcitabine 4 Docetaxel 4 ARRY-334543 4 temsirolimus 3 relatlimab 3 Erlotinib Hydrochloride 3 Cetuximab 3 Carboplatin 3 regorafenib 2 anlotinib 2 abemaciclib 2 Vorinostat 2 Trastuzumab 2 Sorafenib 2 N-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide 2 Magnetic Resonance Spectroscopy 2 Doxorubicin 2 Dasatinib 2 Cyclophosphamide 2 vorolanib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Advanced Cancer × Sunitinib × Clear all

NCT00543504 2020-06-30

Bevacizumab in Multiple Phase I Combinations

M.D. Anderson Cancer Center

Phase 1 Completed

Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡